Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1997-12-18
2000-10-10
Prats, Francisco
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
5147723, 514777, 424426, 424486, 424487, 424488, 6048911, 604 51, 604 48, 604 49, 530351, 530399, A61K 3827, A61K 4730
Patent
active
061302007
ABSTRACT:
Methods and compositions for systemically or locally administering by implantation a beneficial agent to a subject are described, and include, for example, compositions having burst indices of 8 or less for systemic applications and systems releasing 10% or less of the total dose of beneficial agent in the first 24 hours after implantation for local applications. The compositions include a biocompatible polymer, a biocompatible solvent having low water miscibility that forms a viscous gel with the polymer and limits water uptake by the implant, and a beneficial agent.
REFERENCES:
patent: Re35338 (1996-09-01), Haynes
patent: 3636956 (1972-01-01), Schneider
patent: 3714228 (1973-01-01), Massie
patent: 3792010 (1974-02-01), Wasserman et al.
patent: 3923939 (1975-12-01), Baker et al.
patent: 4675189 (1987-06-01), Kent et al.
patent: 4938763 (1990-07-01), Dunn et al.
patent: 4962091 (1990-10-01), Eppstein et al.
patent: 4981696 (1991-01-01), Loomis et al.
patent: 5019400 (1991-05-01), Gombotz et al.
patent: 5077049 (1991-12-01), Dunn et al.
patent: 5085866 (1992-02-01), Consar et al.
patent: 5192741 (1993-03-01), Orsolini et al.
patent: 5242910 (1993-09-01), Damanj
patent: 5278201 (1994-01-01), Dunn et al.
patent: 5278202 (1994-01-01), Sunn et al.
patent: 5292782 (1994-03-01), Bastioli et al.
patent: 5318780 (1994-06-01), Viegas et al.
patent: 5324519 (1994-06-01), Dunn et al.
patent: 5340849 (1994-08-01), Dunn et al.
patent: 5358475 (1994-10-01), Mares et al.
patent: 5368859 (1994-11-01), Dunn et al.
patent: 5447725 (1995-09-01), Damani et al.
patent: 5487897 (1996-01-01), Polson et al.
patent: 5525646 (1996-06-01), Lundren et al.
patent: 5556905 (1996-09-01), Frappier et al.
patent: 5599552 (1997-02-01), Dunn et al.
patent: 5620700 (1997-04-01), Berggren et al.
patent: 5632727 (1997-05-01), Tipton et al.
patent: 5633002 (1997-05-01), Stricker et al.
patent: 5650173 (1997-07-01), Ramstack et al.
patent: 5654010 (1997-08-01), Johnson et al.
patent: 5656297 (1997-08-01), Bernstein et al.
patent: 5660849 (1997-08-01), Polson et al.
patent: 5667808 (1997-09-01), Johnson et al.
patent: 5674534 (1997-10-01), Zale et al.
patent: 5681873 (1997-10-01), Norton et al.
patent: 5702716 (1997-12-01), Dunn et al.
patent: 5707647 (1998-01-01), Dunn et al.
patent: 5711968 (1998-01-01), Tracy et al.
patent: 5716644 (1998-02-01), Zale et al.
patent: 5717030 (1998-02-01), Dunn et al.
patent: 5725491 (1998-03-01), Tipton et al.
patent: 5733566 (1998-03-01), Lewis
patent: 5733567 (1998-03-01), Arola et al.
patent: 5733950 (1998-03-01), Dunn et al.
patent: 5736152 (1998-04-01), Dunn et al.
patent: 5739176 (1998-04-01), Dunn et al.
patent: 5744153 (1998-04-01), Yewey et al.
patent: 5759563 (1998-06-01), Yewey et al.
patent: 5780044 (1998-07-01), Yewey et al.
patent: 5792469 (1998-08-01), Tipton et al.
patent: 5842150 (1998-11-01), Renberg et al.
Yewey, G. L., Duysen, E. G., Cox, S. M., and Dunn, R. L., Chapter 3, "Delivery of Proteins from a Controlled Release Injectable Implant," pp. 93-117, Protein Delivery: Physical Systems, Sanders and Hendren, eds., Plenum Press, New York, 1997.
Modern Plastics Encyclopedia, pp. C99-C109, mid-Nov., 1996.
Nema, S., Washkuhn, R. J., and Brendel, R. J., "Excipients and Their Use in Injectable Products," PDA J. Pharm. Sci. Technol. (United States) Jul.-Aug. 1997, 51 (4), pp. 166-171.
Scotchford, C. A., et al., "Water uptake and protein release characteristics of a new methacrylate-based polymer system," Polymer, vol. 38, No. 15, pp. 3869-3874, 1997.
Johnson, M. L., Jaworowicz, W., Cleland J. L., Bailey, L., Charnis, M., Duenas, E., Wu, C., Shepard, D., Magil, S., Last, T., Jones, A.J.S., and Putney, S. D., "The Stabilization and Encapsulation of Human Growth Hormone into Biodegradable Microspheres," Pharm. Res., vol. 14, No. 6, 1997.
Search Report of WO 98/27962, filed Jul. 2, 1998, published Oct. 1, 1998, Brodbeck, K. J., et al.
Search Report of WO 98/27963, filed Jul. 2, 1998, published Oct. 15, 1998, Brodbeck, K. J., et al.
Cunningham, B. C., Mulkerrin, M. G., Wells, J. A., "Dimerization of Human Growth Hormone by Zinc," Science, vol. 253, pp. 545-548, 1991.
Derwent Abstract (English language) of DE 3635679 A (1988).
Sato, T., Kanke, M., Schroeder, H. G., and DeLuca, P.P., "Porous Biodegradable Microspheres for Controlled Drug Delivery. I. Assessment of Processing Conditions and Solvent Removal Techniques," Pharm. Res. vol. 5, No. 1, pp. 21-30, 1997.
Zhang, Y., Zale, S., Sawyer, L., and Bernstein, H., "Effects of metal salts on poly(DL-lactide-co-glycolide) polymer hydrolysis," J. Biomedical Materials Research, vol. 34, 531-538, 1997.
Brodbeck Kevin J.
Gaynor-Duarte Ann T.
Shen Theodore Tao-Ian
ALZA Corporation
Dhuey John A.
Prats Francisco
Stone Steven F.
LandOfFree
Gel composition and methods does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Gel composition and methods, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gel composition and methods will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2257067